2280 / 2894
2280
Anestesia por subespecialidades en el adulto
IV
244. Muhm JM, Rock PB, McMullin DL, et al: Effect of
aircraft-cabin altitude on passenger discomfort. N
Engl J Med 357:18–27, 2007.
245. Jacobson BF, Munster M, Smith A, et al: The BEST
study—a prospective study to compare business
class versus economy class air travel as a cause of
thrombosis. S Afr Med J 93:522–528, 2003.
246. Board of Science and Education: The Impact of
Flying on Passenger Health: A Guide for Healthcare
Professionals. London, British Medical Association,
2004.
247. Medical Guidelines for Airline Travel, 2nd ed. Aviat
Space Environ Med 74 (2003), A1-19.
248. Christensen CC, Ryg M, Refvem OK, Skjonsberg
OH: Development of severe hypoxaemia in
chronic obstructive pulmonary disease patients at
2,438 m (8,000 ft) altitude. Eur Respir J 15:635–
639, 2000.
249. Christensen CC, Ryg MS, Refvem OK, Skjonsberg
OH: Effect of hypobaric hypoxia on blood gases in
patients with restrictive lung disease. Eur Respir J
20:300–305, 2002.
250. Dillard TA, Beninati WA, Berg BW: Air travel in
patients with chronic obstructive pulmonary
disease. Arch Intern Med 151:1793–1795, 1991.
251. Gong H Jr, Tashkin DP, Lee EY, Simmons MS:
Hypoxia-altitude simulation test: Evaluation of
patients with chronic airway obstruction. Am Rev
Respir Dis 130:980–986, 1984.
252. Vohra KP, Klocke RA: Detection and correction of
hypoxemia associated with air travel. Am Rev
Respir Dis 148:1215–1219, 1993.
253. Martin SE, Bradley JM, Buick JB, et al: Flight
assessment in patients with respiratory disease:
Hypoxic challenge testing vs. predictive equations.
QJM 100:361–367, 2007.
254. Stoller JK: Oxygen and air travel. Respir Care
45:214–221, 2000, discussion 221–222.
255. Muhm JM: Predicted arterial oxygenation at com-
mercial aircraft cabin altitudes. Aviat Space Environ
Med 75:905–912, 2004.
256. Aerospace Medical Association ATMC: Medical
guidelines for air travel. Aviat Space Environ Med
67:B1–16, 2006.
257. Delaune EF 3rd, Lucas RH, Illig P: In-flight medical
events and aircraft diversions: one airline’s expe-
rience. Aviat Space Environ Med 74:62–68, 2003.
258. Buckey JC Jr, Gaffney FA, Lane LD, et al: Central
venous pressure in space. J Appl Physiol 81:19–25,
1996.
259. Leach CS, Alfrey CP, Suki WN, et al: Regulation of
body fluid compartments during short-term space-
flight. J Appl Physiol 81:105–116, 1996.
260. Reschke MF, Bloomberg JJ, Harm DL, et al: Posture,
locomotion, spatial orientation, and motion sick-
ness as a function of space flight. Brain Res Brain
Res Rev 28:102–117, 1998.
261. Buckey JC Jr, Lane LD, Levine BD, et al: Orthostatic
intolerance after spaceflight. J Appl Physiol 81:7–18,
1996.
262. Nyhan D, Kim S, Dunbar S, et al: Impaired pulmo-
nary artery contractile responses in a rat model of
microgravity: Role of nitric oxide. J Appl Physiol
92:33–40, 2002.
263. Perhonen MA, Franco F, Lane LD, et al: Cardiac
atrophy after bed rest and spaceflight. J Appl Physiol
91:645–653, 2001.
264. Tuday EC, Berkowitz DE: Microgravity and cardiac
atrophy: no sex discrimination. J Appl Physiol
103:1–2, 2007.
265. Summers RL, Martin DS, Meck JV, Coleman TG:
Mechanism of spaceflight-induced changes in left
ventricular mass. Am J Cardiol 95:1128–1130, 2005.
266. Edgerton VR, Zhou MY, Ohira Y, et al: Human fiber
size and enzymatic properties after 5 and 11 days of
spaceflight. J Appl Physiol 78:1733–1739, 1995.
267. Williams DR: The biomedical challenges of space
flight. Annu Rev Med 54:245–256, 2003.
268. Kirkpatrick AW, Dulchavsky SA, Boulanger BR, et
al: Extraterrestrial resuscitation of hemorrhagic
shock: Fluids. J Trauma 50:162–168, 2001.
269. Campbell MR: A review of surgical care in space.
J Am Coll Surg 194:802–812, 2002.
270. Campbell MR, Billica RD, Johnston SL 3rd, Muller
MS: Performance of advanced trauma life support
procedures in microgravity. Aviat Space Environ
Med 73:907–912, 2002.
271. Kirkpatrick AW, Nicolaou S, Campbell MR, et al:
Percutaneous aspiration of fluid for management of
peritonitis in space. Aviat Space Environ Med
73:925–930, 2002.
272. Kirkpatrick AW, Hamilton DR, Nicolaou S, et al:
Focused assessment with sonography for trauma in
weightlessness: A feasibility study. J Am Coll Surg
196:833–844, 2003.
273. Keller C, Brimacombe J, A FR, et al: Airway mana-
gement during spaceflight: A comparison of four
airway devices in simulated microgravity. Anesthe-
siology 92:1237–1241, 2000.
274. Beck G: Emergency airway management in orbit:
An evidence-based review of possibilities. Respir
Care Clin North Am 10:401–421, vii, 2004.
275. Rabitsch W, Moser D, Inzunza MR, et al: Airway
management with endotracheal tube versus Com-
bitube during parabolic flights. Anesthesiology
105:696–702, 2006.
276. Marescaux J, Leroy J, Gagner M, et al: Transatlantic
robot-assisted telesurgery. Nature 413:379–380,
2001.
277. Ilyin EA, Korolkov VI, Skidmore MG, et al: Bion 11
mission: Primate experiments. J Gravit Physiol
7:S9–S17, 2000.
278. Norfleet WT: Anesthetic concerns of spaceflight.
Anesthesiology 92:1219–1222, 2000.
279. Agnew JW, Fibuch EE, Hubbard JD: Anesthesia
during and after exposure to microgravity. Aviat
Space Environ Med 75:571–580, 2004.
280. Zhang LF: Vascular adaptation to microgravity:
What have we learned? J Appl Physiol 91:2415–
2430, 2001.
281. Meck JV, Waters WW, Ziegler MG, et al: Mecha-
nisms of post–spaceflight orthostatic hypotension:
Low alpha1-adrenergic receptor responses before
flight and central autonomic dysregulation pos-
tflight. Am J Physiol Heart Circ Physiol 286:H1486–
H1495, 2004.
282. Martin DS, South DA, Wood ML, et al: Comparison
of echocardiographic changes after short- and long-
duration spaceflight. Aviat Space Environ Med
73:532–536, 2002.
283. Tuday EC, Meck JV, NyhanD, et al: Microgravity-indu-
ced changes in aortic stiffness and their role in orthos-
tatic intolerance. J Appl Physiol 102:853–858, 2007.
284. Hawkins WR, Zieglschmid JF: Clinical aspects of
crew health. In Johnston RS, Dietlein LF, Berry CA
(eds): Biomedical Results of Apollo. Washington,
DC, BioTechnology, 1975, pp 43–81.
285. Leach CS, Alexander WC, Johnson PC: Endocrine,
electrolyte, and fluid volume changes associated
with Apollo missions. In Johnston RS, Dietlein LF,
Berry CA (eds): Biomedical Results of Apollo. Was-
hington, DC, BioTechnology, 1975, pp 163–184.
286. Berry CA: Perspectives on Apollo.
In
Johnston RS,
Dietlein LF, Berry CA (eds): Biomedical Results of
Apollo. Washington, DC, BioTechnology, 1975,
pp 581–592.
287. Martyn JA, White DA, Gronert GA, et al: Up-and-
down regulation of skeletal muscle acetylcholine
receptors: Effects on neuromuscular blockers. Anes-
thesiology 76:822–843, 1992.
288. Gronert GA: Disuse atrophy with resistance to
pancuronium. Anesthesiology 55:547–549, 1981.
289. Horton WA, Fergusson NV: Hyperkalaemia and
cardiac arrest after the use of suxamethonium in
intensive care. Anaesthesia 43:890–891, 1988.
290. Hansen D: Suxamethonium-induced cardiac arrest
and death following 5 days of immobilization. Eur
J Anaesthesiol 15:240–241, 1998.
291. Moon RE, Gorman DF: Decompression sickness.
In
Neuman TS, Thom SR (eds): The Physiology and
Medicine of Hyperbaric Oxygen Therapy. Philadel-
phia, Elsevier, 2008.
292. Truss CD, Killenberg PG: Treatment of carbon
tetrachloride with hyperbaric oxygen. Gastroente-
rology 82:767–769, 1982.
293. Berk RF, Lane JM, Patel K: Relationship of oxygen
and glutathione in protection against carbon tetra-
chloride-induced hepatic microsomal lipid peroxi-
dation and covalent binding in the rat: Rationale for
the use of hyperbaric oxygen to treat carbon tetra-
chloride ingestion. J Clin Invest 74:1996–2001,
1984.
294. Davis JC, Heckman JD, DeLee JC, Buckwold FJ:
Chronic non-hematogeneous osteomyelitis treated
with adjuvant hyperbaric oxygen. J Bone Joint Surg
Am 68:1210–1217, 1986.
295. Feldmeier JJ: Hyperbaric Oxygen 2003. The Hyper-
baric OxygenTherapy Committee Report. Kensing-
ton, MD, Undersea and HyperbaricMedical Society,
2003.
296. Price JC, Stevens DL: Hyperbaric oxygen in the
treatment of rhinocerebral mucormycosis. Laryn-
goscope 90:737–747, 1980.
297. Yohai RA, Bullock JD, Aziz AA, Markert RJ: Survival
factors in rhino-orbital-cerebral mucormycosis.
Surv Ophthalmol 39:3–22, 1994.
298. Bouachour G, Cronier P, Gouello JP, et al: Hyper-
baric oxygen therapy in the management of crush
injuries: A randomized double-blind placebo-
controlled clinical trial. J Trauma 41:333–339,
1996.
299. Zamboni WA, Wong HP, Stephenson LL: Effect of
hyperbaric oxygen on neutrophil concentration and
pulmonary sequestration in reperfusion injury.
Arch Surg 131:756–760, 1996.
300. Butler FK, Hagan C, Murphy-Lavoie H: Hyperbaric
oxygen therapy and the eye. Undersea Hyperb Med
35:333–387, 2008.
301. Hammarlund C, Sundberg T: Hyperbaric oxygen
reduced size of chronic leg ulcers: A randomized
double-blind study. Plast Reconstr Surg 93:829–833,
1994.
302. Zamboni WA, Wong HP, Stephenson LL, Pfeifer
MA: Evaluation of hyperbaric oxygen for diabetic
wounds—a prospective study. Undersea Hyperb
Med 24:175–179, 1997.
303. HartGB,O’ReillyRR,BroussardND
,etal:Treatmentof burns with hyperbaric oxygen. Surg Gynecol
Obstet 139:693–696, 1974.
304. Niu AKC, Yang C, Lee HC, et al: Burns treated with
adjunctive hyperbaric oxygen therapy—a compara-
tive study in humans. J Hyperbaric Med 2:75–85,
1987.
305. Cianci P, Lueders HW, Lee H, et al: Adjunctive
hyperbaric oxygen therapy reduces length of hospi-
talization in thermal burns. J Burn Care Rehabil
10:432–435, 1989.
306. Niezgoda JA, Cianci P, Folden BW, et al: The effect
of hyperbaric oxygen therapy on a burn wound
model in human volunteers. Plast Reconstr Surg
99:1620–1625, 1997.
307. Broughton G 2nd: Management of the brown
recluse spider bite to the glans penis. Mil Med
161:627–629, 1996.
308. Maynor ML, Moon RE, Klitzman B, et al: Brown
recluse spider envenomation: A prospective trial of
hyperbaric oxygen therapy. Acad Emerg Med
4:184–192, 1997.